Regeneron Pharmaceuticals Inc
NASDAQ:REGN

Watchlist Manager
Regeneron Pharmaceuticals Inc Logo
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Watchlist
Price: 720.43 USD -0.33%
Market Cap: 75.7B USD

Wall Street
Price Targets

REGN Price Targets Summary
Regeneron Pharmaceuticals Inc

Wall Street analysts forecast REGN stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for REGN is 796.01 USD with a low forecast of 633.27 USD and a high forecast of 1 109.85 USD.

Lowest
Price Target
633.27 USD
12% Downside
Average
Price Target
796.01 USD
10% Upside
Highest
Price Target
1 109.85 USD
54% Upside
Regeneron Pharmaceuticals Inc Competitors:
Price Targets
MRUS
Merus NV
3% Upside
RIGL
Rigel Pharmaceuticals Inc
10% Downside
145020
Hugel Inc
79% Upside
688105
Nanjing Vazyme Biotech Co Ltd
32% Upside
ZYME
Zymeworks Inc
7% Downside
068270
Celltrion Inc
21% Upside
ELIC
Elicera Therapeutics AB
31% Upside
QURE
Uniqure NV
174% Upside

Revenue
Forecast

Revenue Estimate
Regeneron Pharmaceuticals Inc

For the last 13 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's revenue is 31%. The projected CAGR for the next 3 years is 5%.

31%
Past Growth
5%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Regeneron Pharmaceuticals Inc

The compound annual growth rate of Regeneron Pharmaceuticals Inc's operating income for the next 3 years is 12%.

N/A
Past Growth
12%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
Regeneron Pharmaceuticals Inc

The compound annual growth rate of Regeneron Pharmaceuticals Inc's net income for the next 3 years is 8%.

N/A
Past Growth
8%
Estimated Growth
Estimates Accuracy
-11%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is REGN's stock price target?
Price Target
796.01 USD

According to Wall Street analysts, the average 1-year price target for REGN is 796.01 USD with a low forecast of 633.27 USD and a high forecast of 1 109.85 USD.

What is Regeneron Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
5%

For the last 13 years the compound annual growth rate for Regeneron Pharmaceuticals Inc's revenue is 31%. The projected CAGR for the next 3 years is 5%.

What is Regeneron Pharmaceuticals Inc's Operating Income forecast?
Projected CAGR
12%

The compound annual growth rate of Regeneron Pharmaceuticals Inc's operating income for the next 3 years is 12%.

What is Regeneron Pharmaceuticals Inc's Net Income forecast?
Projected CAGR
8%

The compound annual growth rate of Regeneron Pharmaceuticals Inc's net income for the next 3 years is 8%.

Back to Top